Tharimmune Project Introduction, Team, Financing and News_RootData

Market Performance

Tokenized Assets

Ticker	Exchange	Price	24H	Spread	Liquidity ±2%	24H Volume	OI	Funding	Max Leverage	Fees

Event Calendar

Nov 4, 2025

Biotech company Tharimmune raises $540 million in private funding to launch cryptocurrency funding strategy and acquire Canton Network’s native token Canton Coin (CC)

Team

Mark Wendland

Chairman and CEO

Angela Radkowski

COO

Fundraising

LeadLLiberty City Ventures LeadDDRW Venture Capital PPolychain KKraken

AARK Invest